4//SEC Filing
AMYLIN PHARMACEUTICALS INC 4
Accession 0001367982-07-000267
CIK 0000881464operating
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 6:06 PM ET
Size
13.5 KB
Accession
0001367982-07-000267
Insider Transaction Report
Form 4
BARON ALAIN D
Sr VP Research
Transactions
- Exercise/Conversion
Common Stock
2007-06-01$10.94/sh+1,000$10,940→ 16,847 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2007-06-01−3,000→ 54,616 totalExercise: $7.19Exp: 2009-12-08→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2007-06-01$7.19/sh+3,000$21,563→ 18,847 total - Sale
Common Stock
2007-06-01$46.16/sh−3,000$138,480→ 15,847 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2007-06-01−1,000→ 4,042 totalExercise: $10.94Exp: 2012-06-28→ Common Stock (1,000 underlying) - Sale
Common Stock
2007-06-01$46.16/sh−1,000$46,160→ 15,847 total
Footnotes (3)
- [F1]This sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]15,275 options vested on 12/08/2000, and daily after that, until all the 95,000 options were completely vested on 12/08/2003.
- [F3]2,500 options vested on 06/28/02, and monthly after that, until all the 10,000 options were completely vested on 06/28/06.
Documents
Issuer
AMYLIN PHARMACEUTICALS INC
CIK 0000881464
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000881464
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 6:06 PM ET
- Size
- 13.5 KB